home · filing · 0001104659-25-007028
8-K
filed January 29, 2025, 6:59 PM ET
ticker SRRK
CIK 0001727196
leadership
confidence high
sentiment neutral
materiality 0.70
Scholar Rock appoints Lisa Wyman as CTQO; COO role eliminated, CFO search begins
Scholar Rock Holding Corp
Lisa Wyman appointed Chief Technical & Quality Officer effective Jan 27, 2025, reporting to CEO.
Ted Myles, COO & CFO, to remain through Mar 15, 2025, then serve as Senior Advisor until Sep 15, 2025.
Myles receives 9 months base salary, 2024 bonus, prorated $202,400, and 9 months health benefits.
Company expects first drug approval and commercial launch of apitegromab in 2025.
Wyman previously led technical operations at Acceleron, which was sold to Merck for over $11B.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Effective 2025-01-27
Filed January 29, 2025, 6:59 PM ET
announced the appointment of Lisa Wyman, as Chief Technical and Quality Officer of the Company, effective January 27, 2025
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Lisa Wyman was appointed as Chief Technical and Quality Officer at Scholar Rock Holding Corp.
Action appointed
Role Chief Technical and Quality Officer
Exact text from the filing
announced the appointment of Lisa Wyman, as Chief Technical and Quality Officer of the Company, effective January 27, 2025
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-25-007028
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.